Navigation Links
Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting

Company-Sponsored Investor Briefing and Webcast to Follow Presentation

DANBURY, Conn., June 20, 2007 /PRNewswire-FirstCall/ -- Biodel Inc. today announced plans to present clinical results of its leading product candidate, VIAject(TM), at the 67th Annual American Diabetes Association (ADA) Scientific Sessions, to be held in Chicago, June 22 through June 26.

Biodel's oral presentation at the ADA will take place on June 22 from 4:15 - 6:15pm CST, a summary of which will be available on Biodel's website. Following the presentation, the Company will host an investor briefing. Interested parties may access a link to a live audio webcast of the investor briefing in the investor section of Biodel's website at http://www.biodel.com. A replay of the presentation will be available for 14 days.

About Biodel Inc.

Biodel Inc. is a development stage specialty biopharmaceutical company located in Danbury, Connecticut. The Company is focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel develops product candidates by applying proprietary formulation technologies to existing drugs in order to improve their therapeutic results. The Company has two insulin product candidates currently in clinical trials for the treatment of diabetes. Additionally, the Company has two preclinical product candidates for the treatment of osteoporosis.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management are forward- looking statements. The words "anticipates," "b
'"/>




Page: 1 2 3

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/24/2009)...-ChindexInternational,Inc.,("Chindex")(Nasdaq: CHD...ealthcareproductsandservicesinthePeople,sRepublico...1stAnnualPiperJaffray,"Unplugged"HealthCareConfere...tel. , Managementiscurrentlyscheduledtopresen...n-onemeetingsthroughouttheday.Awebcast,ofthepresen...
(Date:11/24/2009)...--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )announc...yHealthcareConferenceonTuesday,December1,2009at9:0...eNewYorkPalaceHotel.SteveWorland,Ph.D.,Presidentan...ewofAnadysanditsclinicaldevelopmentprograms,ANA598...ultaneouslywebcastandcanbeaccessedontheInvestorRel...
(Date:11/24/2009)...rgisMedicalCorp.,asubsidiaryofSpeedusCorp.(Nasdaq:...SE: SI ),todayannouncedthatitsZargisCardioscandevi...EarlyShow duringasegmentinwhichMarkJannot,theedito...ductsfromthepublication,s2009"BestofWhat,sNew"awar...morningnewstalkshowbroadcastbyCBSfromNewYorkCityMo...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3New Reagents from New England Biolabs Bring Purity and Increased Value to Sample Prep for Next Generation Sequencing 57976 1Warsaw Ind Orthopedics Industry and Community Leaders to Make Major Announcement 14208 1Luxury Bed Maker Hstens Introduces Mindspa iPhone 26amp 3B 238482 3B Application 57973 1Luxury Bed Maker Hstens Introduces Mindspa iPhone 26amp 3B 238482 3B Application 57973 2Luxury Bed Maker Hstens Introduces Mindspa iPhone 26amp 3B 238482 3B Application 57973 3
...ighlight significant improvements in RA symptoms ...MRA that specifically targets interleu...m two pivotal,multinational Phase III clinical tri...zumab) significantly improved the signs and sympto...d to adequately respond to,anti-rheumatic therapie...
... Aspirin Therapy Can Safely Take Aleve for ...ts, BOSTON, Nov. 7 Data to be presented at the 7...matology (ACR) showed that when,over- the-counter ...R), was,added to an aspirin therapy regimen, there...rsus baseline. Unlike ibuprofen, which can negate,...
Other Medicine Technology:Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 2Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 3Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 4Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 5Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms 6Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium 2Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium 3Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium 4
(Date:11/25/2009)...rsquo;s Global Intention Heals Project proved that... of someone at a distance. Over 10,000 participant...olunteer who was monitored by a quantitative-EEG. ...and Canada. , Vancouver, ...rsquo;s Global Intention Heals Project proved tha...
(Date:11/25/2009)...ts, generosity will fund much-needed 2010 medical ... (PRWEB) November 25, 2009 -- In its 18th year, &...d $607,700 in proceeds over the course of the 2-da...Board auction of special 2008 Pinot Noir cuv&eacut...ls, over 400 guests bid enthusiastically on oral ...
(Date:11/25/2009)...earemanywaysyoucanimprove,yourhealth,andjustafewsm...beconflictingadviceconcerningwhatisgoodforus,andth...zz.comteamhascompiledalistof25health-boostingtips,...acombinationof,oursuggestedactivitieswillboostyour...hemout. , 1.Reduceyourfatintake.Theeffectsoff...
(Date:11/24/2009)...vide accurate preliminary interpretation of emerge...ding neuroradiologist unavailable, according to re...ma center published in the December issue of the ...CR ). , The accuracy of image interpretation is...y. In most training programs, radiology residents ...
(Date:11/24/2009)...Newswire/--EnigmaDiagnosticsLimited,thedecentralis...uncedtodayfourseniorappointmentsforitsUSandEuropea...residentandCEOwithGregHamilton,ChiefOperatingOffic...newU.S.headquartersinSanDiego,California,theheadqu...annedforassaydevelopment,R&Dandcommercialactiv...
Breaking Medicine News(10 mins):Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 3Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3
...y biologist, in research with implications for peo... insomnia, has determined that the eye uses light ...separate from the ability to see. , The findings ...om development of easier, more available tests to ...
...gift for communicating with infants helps ... FLANDERS, N.J., April 25 In these times of econo...elcome the opportunity to learn,what the future ho...on and on the Web is one indicator that people are...
...Logix, Inc.,(Nasdaq: IFLG ), a leading technology... healthcare and commercial industries, will releas...d March 31, 2008 on Wednesday,April 30th, 2008. Fo... the financial community at 4:30 p.m. (EDT). The,c...
...Duska,Therapeutics, Inc. (OTC Bulletin Board: DSKA...any developing medical products based on adenosine...hnologies, announced today,that the Company,s mana...vascular and Renal Products. The purpose of the,me...
..., shorter hospital stays, study finds , , ...asive laparoscopic surgery to remove pancreatic tu...rter hospital stays, a U.S. study finds. , In lap...s invasive method is widely accepted for gallstone...
...l to help oncologists choose the best therapies fo...n launched this week by scientists at the 1st Euro...he European Society for Medical Oncology (ESMO) an...own somatic mutations (tumor derived - tumor speci...
Other Medicine News:Health News:Different processes govern sight, light detection 2Health News:Internationally Known Psychic Christina Predicts Guides Others to Embrace a More Spiritual Way of Life 2Health News:InfoLogix to Report First Quarter Results on April 30, 2008 2Health News:Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM) 2Health News:Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM) 3Health News:Laparoscopic Surgery on Pancreas Has Fewer Complications 2Health News:Mutation database helps personalized treatment of lung cancer 2
4111R TC Trach Care Tray
...t Solution For Your Tracheostomy Care Needs, ,Eac...s the latest components for efficient and convenie... task. Designed by clinicians, these latex-free tr...nt and caregiver. All of our trays also feature ou...
...t Solution For Your Tracheostomy Care Needs, ,Eac...s the latest components for efficient and convenie... task. Designed by clinicians, these latex-free tr...nt and caregiver. All of our trays also feature ou...
...t Solution For Your Tracheostomy Care Needs, ,Eac...s the latest components for efficient and convenie... task. Designed by clinicians, these latex-free tr...nt and caregiver. All of our trays also feature ou...
Medicine Products: